{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T23:40:09Z","timestamp":1751499609027,"version":"3.41.0"},"reference-count":23,"publisher":"Scientific Scholar","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"abstract":"\n Background & objectives:<\/jats:title>\n Prescription patterns of guideline-directed medical therapy (GDMT) after coronary artery bypass surgery [coronary artery bypass graft (CABG)] and percutaneous coronary intervention (PCI) at hospital discharge are often not optimal. In view of scarce data from the developing world, a retrospective analysis of medication advice to patients following CABG and PCI was conducted.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n Records of 5948 patients (post-PCI: 5152, post-CABG: 796) who underwent revascularization from 2010 to 2014 at a single tertiary care centre in north India were analyzed.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n While age and gender distributions were similar, diabetes and stable angina were more frequent in CABG group. Prescription rates for aspirin 100 per cent versus 98.2 per cent were similar, while beta-blockers (BBs, 95.2 vs 90%), statins (98.2 vs 91.6%), angiotensin-converting enzyme inhibitors (89.4 vs 41.4%), nitrates (51.2 vs 1.1%) and calcium channel blockers (6.6 vs 1.6%) were more frequently prescribed following PCI. Despite similar baseline left ventricular ejection fraction (48.1 vs 51.1%), diuretics were prescribed almost universally post-CABG (98.2 vs 10.9%, P<\/jats:italic><0.001). Nearly all (94.4%) post-CABG patients received a prescription for clopidogrel. Patients undergoing PCI were much more likely to receive higher statin dose; 40-80 mg atorvastatin (72 vs <1%, P<\/jats:italic><0.001) and a higher dose of BB.<\/jats:p>\n <\/jats:sec>\n \n Interpretation & conclusions:<\/jats:title>\n Significant differences in prescription of GDMT between PCI and CABG patients existed at hospital discharge. A substantial proportion of post-CABG patients did not receive BB and\/or statins. These patients were also less likely to receive high-dose statin or optimal BB dose and more likely to routinely receive clopidogrel and diuretics. Such deviations from GDMT need to be rectified to improve quality of cardiac care after coronary revascularization.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/ijmr.ijmr_1905_15","type":"journal-article","created":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T08:42:57Z","timestamp":1523608977000},"page":"722-729","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Do practice gaps exist in evidence-based medication prescription at hospital discharge in patients undergoing coronary artery bypass surgery & coronary angioplasty?"],"prefix":"10.25259","volume":"146","author":[{"given":"Pradeep","family":"Pereira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditya","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Archana","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surendra K","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shantanu","family":"Pande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roopali","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilesh","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudeep","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveen","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satyendra","family":"Tewari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pravin","family":"Goel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","reference":[{"key":"R1-9-20241212","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/j.jacc.2011.10.824","article-title":"AHA\/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: A guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association","volume":"58","author":"Smith","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R2-9-20241212","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1016\/j.jacc.2011.08.009","article-title":"2011 ACCF\/AHA guideline for coronary artery bypass graft surgery. A report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines. Developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons","volume":"58","author":"Hillis","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R3-9-20241212","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2011.08.007","article-title":"2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention. A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions","volume":"58","author":"Levine","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R4-9-20241212","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","article-title":"2014 ESC\/EACTS guidelines on myocardial revascularization: The task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)","volume":"35","author":"Task Force","year":"2014","journal-title":"Eur Heart J"},{"key":"R5-9-20241212","first-page":"e78","article-title":"for American College of Emergency Physicians, Society for Cardiovascular Angiography and Interventions. 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"O\u2019Gara","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R6-9-20241212","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","article-title":"ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology (ESC)","volume":"33","author":"Steg","year":"2012","journal-title":"Eur Heart J"},{"key":"R7-9-20241212","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jacc.2004.09.065","article-title":"Cardiac medical therapy in patients after undergoing coronary artery bypass graft surgery: A review of randomized controlled trials","volume":"45","author":"Okrainec","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R8-9-20241212","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.ahj.2003.07.028","article-title":"Preventing recurrent events long term after coronary artery bypass graft: Suboptimal use of medications in a population study","volume":"147","author":"Bradshaw","year":"2004","journal-title":"Am Heart J"},{"key":"R9-9-20241212","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/sj.jhh.1001469","article-title":"Are we negating the benefits of CABG by forgetting secondary prevention?","volume":"16","author":"Belcher","year":"2002","journal-title":"J Hum Hypertens"},{"key":"R10-9-20241212","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/11598500-000000000-00000","article-title":"Under-prescribing and non-adherence to medications after coronary bypass surgery in older adults: Strategies to improve adherence","volume":"29","author":"Sengstock","year":"2012","journal-title":"Drugs Aging"},{"key":"R11-9-20241212","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/CIRCULATIONAHA.110.981068","article-title":"Secondary prevention after coronary artery bypass graft surgery: Findings of a national randomized controlled trial and sustained society-led incorporation into practice","volume":"123","author":"Williams","year":"2011","journal-title":"Circulation"},{"key":"R12-9-20241212","doi-asserted-by":"crossref","first-page":"I207","DOI":"10.1161\/CIRCULATIONAHA.106.681247","article-title":"Atherosclerosis secondary prevention performance measures after coronary bypass graft surgery compared with percutaneous catheter intervention and nonintervention patients in the get with the guidelines database","volume":"116","author":"Hiratzka","year":"2007","journal-title":"Circulation"},{"key":"R13-9-20241212","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jacc.2012.10.018","article-title":"Use of medications for secondary prevention after coronary bypass surgery compared with percutaneous coronary intervention","volume":"61","author":"Hlatky","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R14-9-20241212","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/sj.ijo.0801748","article-title":"High prevalence of diabetes, obesity and dyslipidaemia in urban slum population in Northern India","volume":"25","author":"Misra","year":"2001","journal-title":"Int J Obes Relat Metab Disord"},{"key":"R15-9-20241212","first-page":"694","article-title":"Coronary artery disease epidemic in Indians: A cause for alarm and call for action","volume":"98","author":"Enas","year":"2000","journal-title":"J Indian Med Assoc"},{"key":"R17-9-20241212","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.athoracsur.2006.10.046","article-title":"Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery","volume":"83","author":"Goyal","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"R18-9-20241212","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/hrt.74.3.235","article-title":"Metoprolol treatment for two years after coronary bypass grafting: Effects on exercise capacity and signs of myocardial ischaemia","volume":"74","author":"Sj\u00f6land","year":"1995","journal-title":"Br Heart J"},{"key":"R19-9-20241212","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/archinte.160.7.947","article-title":"Are beta-blockers effective in elderly patients who undergo coronary revascularization after acute myocardial infarction?","volume":"160","author":"Chen","year":"2000","journal-title":"Arch Intern Med"},{"key":"R20-9-20241212","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jtcvs.2010.03.015","article-title":"Effect of beta-blocker use on outcomes after discharge in patients who underwent cardiac surgery","volume":"140","author":"Chan","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R21-9-20241212","first-page":"e663","article-title":"2012 ACCF\/AHA focused update incorporated into the ACCF\/AHA 2007 guidelines for the management of patients with unstable angina\/non-ST-elevation myocardial infarction: A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"127","author":"Anderson","year":"2013","journal-title":"Circulation"},{"key":"R22-9-20241212","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehr236","article-title":"ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)","volume":"32","author":"Hamm","year":"2011","journal-title":"Eur Heart J"},{"key":"R23-9-20241212","doi-asserted-by":"crossref","first-page":"II24","DOI":"10.1161\/01.cir.0000087654.26917.00","article-title":"Patterns of secondary prevention in older patients undergoing coronary artery bypass grafting during hospitalization for acute myocardial infarction","volume":"108","author":"Foody","year":"2003","journal-title":"Circulation"},{"key":"R24-9-20241212","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/pgmj.2004.023861","article-title":"Patients undergoing coronary revascularisation: A missed opportunity for secondary prevention?","volume":"81","author":"Fox","year":"2005","journal-title":"Postgrad Med J"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/02223309-201746060-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T22:59:38Z","timestamp":1751497178000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijmr.org.in\/do-practice-gaps-exist-in-evidence-based-medication-prescription-at-hospital-discharge-in-patients-undergoing-coronary-artery-bypass-surgery-coronary-angioplasty\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmr.ijmr_1905_15","relation":{},"ISSN":["0971-5916"],"issn-type":[{"type":"print","value":"0971-5916"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}